Announcements Trials
Browse Landscape

Phase

Phase 3 16Phase 2 13Phase 1 4Phase NA 2Phase 2/3 2

Status

Unknown 26Recruiting 19Completed 12Not yet recruiting 5Terminated 4Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Breast Neoplasms 267Prostatic Neoplasms 144Neoplasms 139Lung Neoplasms 84Colorectal Neoplasms 61Motor Activity 55Uterine Cervical Neoplasms 44Carcinoma, Non-Small-Cell Lung 43Pancreatic Neoplasms 35Head and Neck Neoplasms 34Colonic Neoplasms 34Ovarian Neoplasms 33Brain Neoplasms 32Carcinoma, Hepatocellular 27Neoplasm Metastasis 26Rectal Neoplasms 24Stomach Neoplasms 22Melanoma 19Hematologic Neoplasms 19Endometrial Neoplasms 19Liver Neoplasms 18Anxiety Disorders 18Kidney Neoplasms 16Glioma 16Squamous Cell Carcinoma of Head and Neck 15Papillomavirus Infections 15Fatigue 15Esophageal Neoplasms 15Obesity 14Multiple Myeloma 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Active not recruiting × Nasopharyngeal Carcinoma × Clear all
NCT05531916 2026-04-30

CIPN

Sun Yat-sen University

Phase NA Active not recruiting
182 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT07248696 2025-11-25

Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial

Chongqing University Cancer Hospital

Phase NA Active not recruiting
32 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡